Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
9vRTt1FyG2PdvEcU
Listen
